MEDCORP is a global leader in the share financing sector, providing investors with exceptional access to a diverse range of financing opportunities across multiple industries. We employ various structural approaches to meet the needs of our clients and are equipped to serve all jurisdictions, except the People’s Republic of China (PRC), Vietnam, and Pakistan at this time. Clients are afforded access to a comprehensive array of Security Financing opportunities. Our team possesses extensive experience and adheres to a disciplined approach, enabling clients to select counterparties that offer 100% non-rehypothecated, hedged, and trading-structured products that ensure client satisfaction. Currently, we stand as the sole provider of this service within the market.

We are able to impose limited trading clauses on securities deemed risky or volatile, with a cap on hedging set at 15% of total shares. This provision constitutes the most advantageous offering available, exclusively through Medcorp, while the industry standard remains at a 100% hedge. We are at the forefront of innovating non-traded stock loans, which will ultimately serve the interests of our clients and mitigate the occurrences of share manipulation that can lead to artificially induced defaults, a pervasive issue within this sector